Panbela Therapeutics FCF yield
Was ist das FCF yield von Panbela Therapeutics?
FCF yield von Panbela Therapeutics Inc. ist -2,192.33%
Was ist die Definition von FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Panbela Therapeutics
Was macht Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Unternehmen mit fcf yield ähnlich Panbela Therapeutics
- Touchpoint hat FCF yield von -2,790.72%
- Valeritas hat FCF yield von -2,715.90%
- Rhino Resource Partners LP hat FCF yield von -2,676.97%
- CARBO Ceramics hat FCF yield von -2,674.78%
- Shiloh Industries hat FCF yield von -2,671.82%
- Briggs & Stratton hat FCF yield von -2,633.23%
- Panbela Therapeutics hat FCF yield von -2,192.33%
- KKR & Co hat FCF yield von -2,145.36%
- Endologix hat FCF yield von -1,961.27%
- Basler Aktiengesellschaft hat FCF yield von -1,839.17%
- Zovio Inc hat FCF yield von -1,838.52%
- PhaseBio Pharmaceuticals hat FCF yield von -1,833.88%
- Tailored Brands hat FCF yield von -1,823.08%